Occudo Quantitative Strategies LP Compugen LTD Transaction History
Occudo Quantitative Strategies LP
- $500 Million
- Q4 2024
Shares
3 transactions
Others Institutions Holding CGEN
# of Institutions
80Shares Held
13.4MCall Options Held
44.9KPut Options Held
8.1K-
Silverarc Capital Management, LLC1.62MShares$3.01 Million0.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.28MShares$2.36 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.09MShares$2.02 Million0.85% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.89 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD990KShares$1.83 Million0.06% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $160M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...